(Q46308402)

21 December 2017

title

Immunomodulatory effects of soluble factors secreted by feline adipose tissue-derived mesenchymal stem cells (English)

1 reference

21 December 2017

main subject

mesenchymal stem cell

1 reference

Hyung-Kyu Chae

1

1 reference

21 December 2017

Woo-Jin Song

2

1 reference

21 December 2017

Jin-Ok Ahn

3

1 reference

21 December 2017

Qiang Li

4

1 reference

21 December 2017

Bo-Yeon Lee

5

1 reference

21 December 2017

Kyeong Kweon

6

1 reference

21 December 2017

Sang-Chul Park

7

1 reference

21 December 2017

Hwa-Young Youn

8

1 reference

21 December 2017

publication date

31 July 2017

1 reference

21 December 2017

Veterinary Immunology and Immunopathology

published in

1 reference

21 December 2017

volume

191

1 reference

21 December 2017

page(s)

22-29

1 reference

21 December 2017

Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Human mesenchymal stem cells modulate allogeneic immune cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Lipopolysaccharide-stimulated RAW 264.7 macrophage inducible nitric oxide synthase and nitric oxide production is decreased by an omega-3 fatty acid lipid emulsion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Macrophage cytokines: involvement in immunity and infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Mesenchymal stromal cells: sensors and switchers of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Human mesenchymal stem cells modulate B-cell functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Mechanisms of mesenchymal stromal cell immunomodulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

MSC: a coming of age in regenerative medicine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derived mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Biological characterization of long-term cultured human mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Targeting improves MSC treatment of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Mesenchymal stromal cell 'licensing': a multistep process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Secretion of immunoregulatory cytokines by mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Sequential sub-passage decreases the differentiation potential of canine adipose-derived mesenchymal stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Immunobiology of mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Molecular characterization and in vitro differentiation of feline progenitor-like amniotic epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Crucial role of interferon-gamma and stimulated macrophages in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Long-term evaluation of mesenchymal stem cell therapy in a feline model of chronic allergic asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Mesenchymal stem cells in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

The role of mesenchymal stem cells in veterinary therapeutics - a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

Therapeutic doses of multipotent stromal cells from minimal adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2017.07.013

10.1016/J.VETIMM.2017.07.013

7 January 2021

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017